Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
about
Platelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesGuarding the perimeter: protection of the mucosa by tissue-resident memory T cellsHow specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depthCritical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesisAn AGM model for changes in complement during pregnancy: neutralization of influenza virus by serum is diminished in late third trimesterRandomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskCross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesOriginal Antigenic Sin Response to RNA Viruses and Antiviral ImmunityOne health, multiple challenges: The inter-species transmission of influenza A virusBiogenesis of influenza a virus hemagglutinin cross-protective stem epitopesSouthern Hemisphere Influenza and Vaccine Effectiveness Research and SurveillanceTwo years after pandemic influenza A/2009/H1N1: what have we learned?Seroprevalence to influenza A(H1N1) 2009 virus--where are we?Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virusActivation of coagulation and tissue fibrin deposition in experimental influenza in ferretsCharacterization of pandemic influenza immune memory signature after vaccination or infection.Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease courseHeterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung.Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort.H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccination.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Influenza and dengue virus co-infection impairs monocyte recruitment to the lung, increases dengue virus titers, and exacerbates pneumonia.MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.Influenza A viruses: new research developments.The pathogenesis of influenza virus infections: the contributions of virus and host factorsProspective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy.Interaction between innate immunity and porcine reproductive and respiratory syndrome virus.Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.Case report: Increased viral receptor expression associated with high viral load and severe pneumonia in a young patient infected with 2009 H1N1 influenza a with no pre-existing conditions.Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.Sociodemographic factors and clinical conditions associated to hospitalization in influenza A (H1N1) 2009 virus infected patients in Spain, 2009-2010.Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients.Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.Increased viral loads and exacerbated innate host responses in aged macaques infected with the 2009 pandemic H1N1 influenza A virus.Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky.
P2860
Q26739670-C726B27F-C90D-46D6-9AE1-C7F3400568EBQ26822643-8E6242CD-8AFE-43B0-8A2A-A535B8CAE235Q27026728-185E0975-3A10-4091-99F5-8757461D1047Q27302959-0A647955-203D-46C6-AA8E-B61DC9F1DD4EQ27326934-5137226D-4CA5-4BBE-A09F-DB59CEB6E683Q27330166-D6553D95-BCF1-4BDB-AA87-10EFC0FCE386Q27348520-C7EBCEAA-EEA9-4DB8-8C50-66D47D7185C4Q28066918-E2085139-268B-43C7-9B73-6E39FBEB3519Q28386183-78B764AC-AA55-4FBD-90E2-1133019FC77CQ28539672-CD72C97A-E831-499B-93FA-E8D3FD118B97Q30204000-C0700213-EDB9-4EAD-BF35-F799B6CC6683Q30224656-BDCC890A-2044-49D6-BD59-79536E4AAA26Q30226546-7CF208A7-BF2B-4C55-BD76-B6C6F9ACD927Q30360439-644A5ED4-70D3-46DC-867F-438CC492BB02Q30363101-5062DF3D-E346-43A8-A22D-F06E87312D7DQ30363416-A3DC59E4-E6F0-4309-B828-E8631C39AF83Q30363631-1259BBA5-D0F2-4968-831A-E3EC661131EDQ30366138-DFA51A81-8C6A-4736-9038-1E1A876B7333Q30369574-EAFBAA46-1FE3-4C07-8953-F1D6E42958ACQ30371297-3C3D3022-587A-42B3-B987-A547F06BF71FQ30395259-DEAE4C6B-3C14-4731-A75A-DFB6DAAAED26Q30396651-ED3FB3A3-4027-45FD-8ACC-CF36D5D9E9FAQ30403361-959F1C66-A5A1-401A-8899-2847511A6CABQ30404670-0A877F4E-AA55-4556-B52E-05A1464C93D7Q30405941-8E62E4FE-A281-4A92-91B3-3379AE7A308BQ30408415-AE574785-F2D2-425B-84EE-98F9F04C8673Q30410415-08EC9456-9917-49D6-B61E-EA79F9E89226Q30411189-1E85F775-4A8D-41C6-9564-75EF867F8012Q30411777-629BD041-12AC-4096-AC42-DD711929229EQ30413677-069DB5C4-3FCB-46CC-BE95-83B5E803E4B5Q30414153-4603FF5E-86F8-488A-A58C-FE5C16BA27AAQ30414225-C1C2420F-1A23-4FE5-AF78-A19AA4327856Q30414286-17ADB593-1CFF-411A-AEE9-C116A715E908Q30414781-191DFAD0-D44F-4D7B-8FAD-8D7B7BEC7127Q30415511-A0CC559A-B27E-43FB-9872-054438956071Q30416598-9B767278-16E0-4BEB-9B0E-124CED502154Q30419959-D96FB0A9-E93C-4F93-ADDF-A0685FEBA47DQ30420990-C411B8F0-CD94-4C8B-BB0C-B44D1E7D13C9Q30421821-9D88C26B-239F-46FF-B56F-A8AA6C1FBEC8Q30424643-56C5823B-3593-402E-A02B-A8CA73D6A5AB
P2860
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
@ast
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
@en
type
label
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
@ast
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
@en
prefLabel
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
@ast
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
@en
P2093
P2860
P50
P356
P1433
P1476
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
@en
P2093
Ana Clara Monsalvo
Bernardo Maskin
Carlos Rubinstein
Elsa Baumeister
Fernando P Polack
Graciela Cabral
Guillermina A Melendi
Jennifer Klemenc
Jens C Krause
Jimena Bugna
P2860
P2888
P304
P356
10.1038/NM.2262
P407
P577
2010-12-05T00:00:00Z